immatics Biotechnologies GmbH
Über Immatics Biotechnologies
immatics is developing cancer drugs that help to activate the self defense mechanisms of the human body.
Our goal is to support patients and physicians with new options in the fight against various cancers.
Our means are synthetic peptides that specifically activate specialized white blood cells of the patient’s immune system against cancer cells.
Fakten zu Immatics Biotechnologies
Fakten zu Immatics Biotechnologies
- Schwerpunkt : Hersteller
- Mitarbeiter: 51-200
- Branche : Biotechnologie
